CIK 0000818033
- Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 942875566
- Phone
- +1 858-251-4400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- 4 Option exercise EVP, Chief Development Officer acquired 23,464 shares (option exercise)
- 4 Option exercise EVP, Chief Financial Officer acquired 25,229 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 84,810 shares (option exercise)
- 4 Option exercise EVP, Chief Development Officer acquired 3,874 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 13,797 shares (option exercise)
- 4 Option exercise EVP, Chief Financial Officer acquired 3,874 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 62,500 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 53,960 shares (grant or award)
- 4 Grant or award Director acquired 53,960 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 53,960 shares (grant or award)
- 4 Grant or award Director acquired 53,960 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 53,960 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 53,960 shares (grant or award)
- 4 Option exercise EVP, Chief Financial Officer acquired 11,695 shares (option exercise)
- 4 Option exercise EVP, Chief Development Officer acquired 11,695 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 34,789 shares (option exercise)
Page 2 of 30 · 585 filings